The purpose of this contract is to provide product development services utilizing biochemical and cell-based assays in both standard and high throughput screening (HTS) formats. These services…

Ended Indefinite Delivery Contract Awarded Last action

Contract number
HHSN272201400010I
Awardee
Awarding agency
Task orders
44 $18,268,541 obligated

Award facts

Opportunity
Combined order value
$18,268,541 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 75% used
$24,293,824.00
Maximum order
$24,293,824.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

This Indefinite Delivery Contract (IDC) was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Southern Research Institute, a non-profit organization. The contract, valued at up to $24,293,824, is for an "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" and does not have a set-aside designation.

Under this IDC, Southern Research Institute is providing a range of services, including optimization and synthesis of anti-HIV lead compounds, high-throughput screening to identify HIV inhibitors, assay development and validation, and other preclinical activities to support the development of HIV therapeutics and topical microbicides. The work is being performed at Southern Research Institute's facility in Birmingham, Alabama. The IDC has a period of performance through July 31, 2021, with multiple delivery orders issued to date for specific tasks under this broader contract vehicle.

Description

As the agency reported it.

The purpose of this contract is to provide product development services utilizing biochemical and cell-based assays in both standard and high throughput screening (HTS) formats. These services assist a wide variety of investigators in obtaining criti

Task orders

Task order Ordering agency Obligated Awarded
The contractor shall carry out activities required for the optimization, development, and synthesis of lead anti-HIV… 75N93020F00005 National Institute of Allergy and Infectious Diseases (NIH) $749,998
The contractor shall test interventional agents in atory and specialized assays in standard format (i.e., cell… 75N93020F00001 National Institute of Allergy and Infectious Diseases (NIH) $146,812
The contractor shall acquire and store chemical compound libraries and conduct screening of interventional agents… 75N93020F00002 National Institute of Allergy and Infectious Diseases (NIH) $111,431
The contractor shall carry out activities required for the optimization, development, and synthesis of lead… 75N93020F00004 National Institute of Allergy and Infectious Diseases (NIH) $494,934
The contractor shall perform assay development and validation to identify and evaluate efficacy of anti-HIV… 75N93020F00003 National Institute of Allergy and Infectious Diseases (NIH) $214,117
The contractor shall adapt an HIV-1 TAT inhibition assay from DR. Susana valente of the scripps research institute… 75N93019F00135 National Institute of Allergy and Infectious Diseases (NIH) $499,682
The contractor shall carry out activities required for the optimization, development, and synthesis of lead… 75N93019F00134 National Institute of Allergy and Infectious Diseases (NIH) $497,408
The contractor shall perform assay development and validation to identify and evaluate efficacy of anti-HIV… 75N93019F00133 National Institute of Allergy and Infectious Diseases (NIH) $300,228
The contractor shall acquire and store chemical compound libraries and conduct screening of interventional agents… 75N93019F00132 National Institute of Allergy and Infectious Diseases (NIH) $99,623
The contractor shall test interventional agents in confirmatory and specialized assays in standard format (i.e., cell… 75N93019F00131 National Institute of Allergy and Infectious Diseases (NIH) $165,000
The contractor shall carry out activities required for the optimization, development, and synthesis of lead… 75N93018F00034 National Institute of Allergy and Infectious Diseases (NIH) $1,997,772
The contractor shall carry out activities required for the optimization, development, and synthesis of lead… 75N93018F00033 National Institute of Allergy and Infectious Diseases (NIH) $499,816
The contractor shall acquire and store chemical compound libraries and conduct screening of interventional agents… 75N93018F00031 National Institute of Allergy and Infectious Diseases (NIH) $99,998
The contractor shall test interventional agents in confirmatory and specialized assays in standard format (i.e., cell… 75N93018F00030 National Institute of Allergy and Infectious Diseases (NIH) $174,999
The contractor shall perform assay development and validation to identify and evaluate efficacy of anti-HIV… 75N93018F00032 National Institute of Allergy and Infectious Diseases (NIH) $295,565
Identification of anti-HIV lead compounds HHSN27200028 National Institute of Allergy and Infectious Diseases (NIH) $319,626
Annual update of the national center for biotechnology information (ncbi) database HHSN27200029 National Institute of Allergy and Infectious Diseases (NIH) $271,236
New assay development HHSN27200027 National Institute of Allergy and Infectious Diseases (NIH) $146,836
High throughput screening to identify HIV inhibitors HHSN27200026 National Institute of Allergy and Infectious Diseases (NIH) $386,510
Identification of anti-HIV therapeutics and topical microbicides HHSN27200025 National Institute of Allergy and Infectious Diseases (NIH) $684,610
HTS to identify inhibitors of HIV-1 capsid dimerization HHSN27200024 National Institute of Allergy and Infectious Diseases (NIH) $999,976
HTS to identify inhibitors or HIV-1 VPU HHSN27200023 National Institute of Allergy and Infectious Diseases (NIH) $769,798
Annual update of the national center for biotechnology information (ncbi) database HHSN27200021 National Institute of Allergy and Infectious Diseases (NIH) $257,507
New assay development HHSN27200019 National Institute of Allergy and Infectious Diseases (NIH) $128,313
Identification of lead compounds to inhibit HIV-1 regulatory proteins HHSN27200022 National Institute of Allergy and Infectious Diseases (NIH) $516,565
Identification of anti-HIV lead compounds HHSN27200020 National Institute of Allergy and Infectious Diseases (NIH) $257,889
Identification of anti-HIV therapeutics and topical microbicides HHSN27200017 National Institute of Allergy and Infectious Diseases (NIH) $516,234
High throughput screening to identify HIV inhibitors HHSN27200018 National Institute of Allergy and Infectious Diseases (NIH) $254,077
Identification of lead compounds to inhibit HIV HHSN27200016 National Institute of Allergy and Infectious Diseases (NIH) $499,880
High throughput screening to identify HIV inhibitors HHSN27200011 NIAID DEA OA Acquisitions (NIH) $249,990
Identification of anti-HIV lead compounds HHSN27200013 NIAID DEA OA Acquisitions (NIH) $249,997
Identification of anti-HIV therapeutics and topical microbicides HHSN27200010 National Institute of Allergy and Infectious Diseases (NIH) $496,283
New assay development HHSN27200012 National Institute of Allergy and Infectious Diseases (NIH) $124,877
500,000 compound screen to identify GAG processing inhibitors HHSN27200015 NIAID DEA OA Acquisitions (NIH) $749,989
Annual update of the national center for biotechnology information (ncbi) database HHSN27200014 National Institute of Allergy and Infectious Diseases (NIH) $247,318
In vitro screening of interventional agents in HTS formats: 700,000 compound screen of VIF/apobec inhibitors HHSN27200007 National Institute of Allergy and Infectious Diseases (NIH) $849,340
Administation and data coordination: annual update of the ncbi database HHSN27200006 National Institute of Allergy and Infectious Diseases (NIH) $263,415
Conduct HIT-to-lead progression studies on intervention agents: VIF dimerization inhibitors HHSN27200009 National Institute of Allergy and Infectious Diseases (NIH) $351,656
Conduct HIT-to-lead progression studies on intervention agents: VIF/apobec inhibitors HHSN27200008 National Institute of Allergy and Infectious Diseases (NIH) $350,539
HHSN27200002 NIAID DEA OA Acquisitions (NIH) $275,547
HHSN27200003 National Institute of Allergy and Infectious Diseases (NIH) $252,160
HHSN27200004 National Institute of Allergy and Infectious Diseases (NIH) $160,390
HHSN27200005 National Institute of Allergy and Infectious Diseases (NIH) $376,639
Admin change to privacy act applicable HHSN27200001 National Institute of Allergy and Infectious Diseases (NIH) $913,962
Show all 44

Transactions

Action Obligated Date
Other Administrative Action P00007 $0
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award In vitro testing resource for HIV therapeutics and topical microbicides $0

Quick answers

Who was awarded contract HHSN272201400010I?

HHSN272201400010I was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 30, 2014.

How much is contract HHSN272201400010I worth?

Orders under HHSN272201400010I have obligated $18,268,541. HHSN272201400010I's own ceiling is $24,293,824. A single order can be worth up to $24,293,824.

How many orders have been placed under contract HHSN272201400010I?

44 orders have been placed under HHSN272201400010I, the latest on September 21, 2020.

Who can order from contract HHSN272201400010I?

HHSN272201400010I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSN272201400010I competed?

The extent of competition for HHSN272201400010I was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login